EWA
BSX icon

Exencial Wealth Advisors’s Boston Scientific BSX Stock Holding History

Exencial Wealth Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.73M Buy
123,124
+120,607
+4,792% +$9.65M 0.24% 107
2025
Q4 		$240K Sell
2,517
-421
-14% -$41.3K 0.01% 506
2025
Q3 		$287K Buy
2,938
+304
+12% +$31.5K 0.01% 459
2025
Q2 		$283K Buy
2,634
+88
+3% +$8.9K 0.01% 437
2025
Q1 		$257K Buy
+2,546
New +$256K 0.01% 445

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Exencial Wealth Advisors's BSX Position: Q1 2026 in Review

Exencial Wealth Advisors increased its Boston Scientific (BSX) stake by 4,792% in Q1 2026, buying an estimated $9.65M and bringing the position to 123,124 shares worth $7.73M. The position accounts for 0.24% of the portfolio, ranked #107.

Exencial Wealth Advisors first reported a position in BSX in Q1 2025 and has held it in 5 quarters since. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Exencial Wealth Advisors held 123,124 shares of Boston Scientific worth $7.73M as of Q1 2026.
  • Exencial Wealth Advisors bought 120,607 Boston Scientific shares in Q1 2026, an estimated $9.65M.
  • Boston Scientific made up 0.24% of Exencial Wealth Advisors's portfolio in Q1 2026, its #107 holding.
  • Exencial Wealth Advisors first reported a position in Boston Scientific in Q1 2025 and has held it in 5 quarters since.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Exencial Wealth Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.